Didier Coquoz
Geen lopende functies
Profiel
Didier Coquoz founded BioLingus (Cayman) Ltd.
in 2018.
Dr. Coquoz also formerly worked at Cytune Pharma SAS, as Chief Development Officer.
Dr. Coquoz received his graduate degree from the University of Geneva.
Eerdere bekende functies van Didier Coquoz
| Bedrijven | Functie | Einde |
|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Corporate Officer/Principal | 01-12-2014 |
BioLingus (Cayman) Ltd.
 BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Oprichter | - |
Opleiding van Didier Coquoz
| University of Geneva | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Cytune Pharma SAS
Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France. | Commercial Services |
BioLingus (Cayman) Ltd.
BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Commercial Services |
